Clinical TrialsSearch results
Number of results: 2568
Completed
- A Phase Ia/Ib Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of Tiragolumab as a Single Agent and in Combination With Atezolizumab and/or Other Anti-Cancer Therapies in Patients With Locally Advanced or Metastatic Tumors
- locally advanced, recurrent, or metastatic tumors
- Tien Hoang
- 2021-11-19
Completed
- A phase I/II study of hybrid brachytherapy for locally advanced cervical carcinoma
- Uterine cervical cancer
- Igaki Hiroshi
- 2019-03-12
Completed
- A Phase I, Single-dose Study with SB206 in Healthy Japanese Adults
- Molluscum contagiosum
- Tsubouchi Ichiro
- 2022-05-19
Completed
- A Phase I Study of TR-012001 in Healthy Japanese Adult Males
- Parkinson's Disease
- Kanazashi Shuichi
- 2022-03-10
Completed
- A Phase 3, Randomized, Open-Label, Controlled, Multicenter Study of Zandelisib (ME-401) in Combination with Rituximab Versus Standard Immunochemotherapy in Patients with Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL) - The COASTAL Study
- Follicular Lymphoma, Marginal zone lymphoma
- Hanaya Miyoko
- 2023-05-15
Completed
- A Phase 3, Randomized, Active-Comparator, Observer-Blind, Non-Inferiority Study of DS-5670a in Adults Aged 18 Years and Older
- Prevention of infectious disease by Severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)
- Inoguchi Akihiro
- 2022-08-10
Completed
- A Phase 2b Randomised, Double-Blind, Placebo-Controlled, Multi-Centre, Dose-Ranging Study of AZD5718 in Participants With Proteinuric Chronic Kidney Disease
- Chronic Kidney Disease
- Hibi Kazushige
- 2020-11-16
Completed
- A phase 2, randomized, placebo-controlled, double-blind, dose-finding study of TS-172 in hyperphosphatemia patients on hemodialysis
- Hyperphosphatemia
- Mita Seiji
- 2023-01-22
Completed
- A Phase 2, Open Label, Randomized Study of the Efficacy and Safety of Acalabrutinib With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19
- COVID-19
- Hibi Kazushige
- 2024-03-28
Completed
- A Phase 1 Study of Olorofim in Healthy Japanese and Caucasian Participants
- Healthy adult participants
- Nagata Tsutae
- 2023-04-10